I-Mab - Stock Price History | IMAB

Historical daily share price chart and data for I-Mab since 2021 adjusted for splits. The latest closing stock price for I-Mab as of September 23, 2021 is 70.30.
  • The all-time high I-Mab stock closing price was 84.43 on July 01, 2021.
  • The I-Mab 52-week high stock price is 85.40, which is 21.5% above the current share price.
  • The I-Mab 52-week low stock price is 32.64, which is 53.6% below the current share price.
  • The average I-Mab stock price for the last 52 weeks is 57.55.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
I-Mab Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 27.2118 13.8000 47.1500 10.6300 47.1500 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.893B $0.236B
I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71